Particle-bound DNA polymerase activity in haematological disorders and normal controls
- PMID: 7130242
- PMCID: PMC12252748
- DOI: 10.1007/BF00402062
Particle-bound DNA polymerase activity in haematological disorders and normal controls
Abstract
A DNA polymerase present in particles with a density greater than 1.20 g/cm3 and capable of using a synthetic RNA template has been sought in human malignancies. This report deals with a study of a great number of peripheral-blood samples from normal controls and patients with malignant and non-neoplastic haematological disorders. For screening purposes a simplified detection test was used. In 63 controls low levels of enzyme activity were found. The enzyme activities showed a biphasic distribution pattern. Three out of 53 patients with non-neoplastic, miscellaneous haematological disorders had an elevated enzyme level associated with active viral infections (hepatitis, mononucleosis infectiosa). In 128 patients suffering from haematological malignancies 18 out of 21 cases of elevated enzyme level were associated with the presence of more than 10% pathological cells in the white blood cell fraction.
Similar articles
-
Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support.Cochrane Database Syst Rev. 2017 Jan 27;1(1):CD011305. doi: 10.1002/14651858.CD011305.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2024 May 23;5:CD011305. doi: 10.1002/14651858.CD011305.pub3. PMID: 28128441 Free PMC article. Updated.
-
Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.Cochrane Database Syst Rev. 2015 Nov 18;2015(11):CD010983. doi: 10.1002/14651858.CD010983.pub2. Cochrane Database Syst Rev. 2015. PMID: 26576687 Free PMC article.
-
Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.Cochrane Database Syst Rev. 2015 Oct 27;2015(10):CD010984. doi: 10.1002/14651858.CD010984.pub2. Cochrane Database Syst Rev. 2015. PMID: 26505729 Free PMC article.
-
Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.Cochrane Database Syst Rev. 2012 May 16;2012(5):CD004269. doi: 10.1002/14651858.CD004269.pub3. Cochrane Database Syst Rev. 2012. PMID: 22592695 Free PMC article.
-
A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.Cochrane Database Syst Rev. 2015 Sep 30;2015(9):CD010981. doi: 10.1002/14651858.CD010981.pub2. Cochrane Database Syst Rev. 2015. PMID: 26422767 Free PMC article.
References
-
- Baxt W, Hehlman R, Spiegelman S (1972) Human leukemic cells contain reverse transcriptase associated with a high molecular weight virus-related RNA. Nature (New Biol) 240:72–75 - PubMed
-
- Chandra P, Steel LK, Laube H, Kornhuber B (1975) Oncornaviral-like DNA polymerase activity in a case of childhood myelofibrotic syndrome. FEBS Lett 58:71–75 - PubMed
-
- Gallo RC, Yang SS Ting, Ting RC (1970) RNA dependent DNA polymerase of human acute leukemic cells. Nature 229:927–929 - PubMed
-
- Gross J (1970) Oncogenic viruses. 2nd edn. Pergamon Press, Oxford
-
- Herbrink P, Moen JET, Brouwer J, Warnaar SO (1980a) Detection of antibodies cross-reactive with type-C RNA tumor viral p30 protein in human sera and exudate fluids. Cancer Res 40:166–173 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical